Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.
The report details the trend, potential and market size of Arginase Deficiency Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Arginase Deficiency Therapeuticsmarket, defines the market attractiveness level of Arginase Deficiency Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Arginase Deficiency Therapeutics industry, describes the types of Arginase Deficiency Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Arginase Deficiency Therapeutics market and the development prospects and opportunities of Arginase Deficiency Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Arginase Deficiency Therapeutics market in Chapter 13.
By Player:
Novartis Pharmaceuticals
Medicis Pharmaceutical
Horizon Pharma
Helsinn Healthcare
By Type:
Oral
Injection
By End-User:
Hospital
Drugs Stores
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Arginase Deficiency Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Arginase Deficiency Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Arginase Deficiency Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Arginase Deficiency Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Arginase Deficiency Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Arginase Deficiency Therapeutics Consumption (2017-2022)
-
7.2 United States Arginase Deficiency Therapeutics Consumption (2017-2022)
-
7.3 Europe Arginase Deficiency Therapeutics Consumption (2017-2022)
-
7.4 China Arginase Deficiency Therapeutics Consumption (2017-2022)
-
7.5 Japan Arginase Deficiency Therapeutics Consumption (2017-2022)
-
7.6 India Arginase Deficiency Therapeutics Consumption (2017-2022)
-
7.7 South Korea Arginase Deficiency Therapeutics Consumption (2017-2022)
8 Region and Country-wise Arginase Deficiency Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Arginase Deficiency Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Arginase Deficiency Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Arginase Deficiency Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Arginase Deficiency Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Arginase Deficiency Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Arginase Deficiency Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Arginase Deficiency Therapeutics Consumption Forecast (2022-2028)
9 Global Arginase Deficiency Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Arginase Deficiency Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Arginase Deficiency Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Stores Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Arginase Deficiency Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Arginase Deficiency Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Arginase Deficiency Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Arginase Deficiency Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Arginase Deficiency Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Arginase Deficiency Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Arginase Deficiency Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Arginase Deficiency Therapeutics Market Competitive Analysis
-
14.1 Novartis Pharmaceuticals
-
14.1.1 Novartis Pharmaceuticals Company Details
-
14.1.2 Novartis Pharmaceuticals Arginase Deficiency Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Pharmaceuticals Arginase Deficiency Therapeutics Product and Service
-
14.2 Medicis Pharmaceutical
-
14.2.1 Medicis Pharmaceutical Company Details
-
14.2.2 Medicis Pharmaceutical Arginase Deficiency Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Medicis Pharmaceutical Arginase Deficiency Therapeutics Product and Service
-
14.3 Horizon Pharma
-
14.3.1 Horizon Pharma Company Details
-
14.3.2 Horizon Pharma Arginase Deficiency Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Horizon Pharma Arginase Deficiency Therapeutics Product and Service
-
14.4 Helsinn Healthcare
-
14.4.1 Helsinn Healthcare Company Details
-
14.4.2 Helsinn Healthcare Arginase Deficiency Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Helsinn Healthcare Arginase Deficiency Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Arginase Deficiency Therapeutics
-
Figure Arginase Deficiency Therapeutics Picture
-
Table Global Arginase Deficiency Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Arginase Deficiency Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Arginase Deficiency Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Arginase Deficiency Therapeutics Consumption by Country (2017-2022)
-
Figure United States Arginase Deficiency Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Arginase Deficiency Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Arginase Deficiency Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Arginase Deficiency Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Arginase Deficiency Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Arginase Deficiency Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Arginase Deficiency Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Arginase Deficiency Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Arginase Deficiency Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Arginase Deficiency Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Arginase Deficiency Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Arginase Deficiency Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Arginase Deficiency Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Arginase Deficiency Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Arginase Deficiency Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Novartis Pharmaceuticals Arginase Deficiency Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Pharmaceuticals Arginase Deficiency Therapeutics Product and Service
-
Table Medicis Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Medicis Pharmaceutical Arginase Deficiency Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medicis Pharmaceutical Arginase Deficiency Therapeutics Product and Service
-
Table Horizon Pharma (Foundation Year, Company Profile and etc.)
-
Table Horizon Pharma Arginase Deficiency Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Pharma Arginase Deficiency Therapeutics Product and Service
-
Table Helsinn Healthcare (Foundation Year, Company Profile and etc.)
-
Table Helsinn Healthcare Arginase Deficiency Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Helsinn Healthcare Arginase Deficiency Therapeutics Product and Service
-
